• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用合成表面活性剂治疗的早产兔的肺功能

Lung function in prematurely delivered rabbits treated with a synthetic surfactant.

作者信息

Tooley W H, Clements J A, Muramatsu K, Brown C L, Schlueter M A

出版信息

Am Rev Respir Dis. 1987 Sep;136(3):651-6. doi: 10.1164/ajrccm/136.3.651.

DOI:10.1164/ajrccm/136.3.651
PMID:3307569
Abstract

We treated prematurely delivered rabbit pups with the synthetic surfactant that has been named Exosurf. By weight, Exosurf is 61.8% dipalmitoylphosphatidylcholine, 6.8% hexadecanol, 4.6% tyloxapol, and 26.7% NaCl. This simple mixture, suspended at 15 mg lipid X ml-1 water, has appropriate in vitro characteristics for a lung surfactant substitute. As determined by static pressure volume relationships performed after 30 min ventilation, lungs treated with Exosurf accepted significantly more gas at maximal inflation (36 versus 15 ml X kg-1 body weight) and had significantly greater volumes during deflation that did saline-treated control lungs; lungs treated with natural rabbit surfactant (SAM) had significantly larger volumes at maximal inflation (65 versus 35 ml X kg-1) and during deflation than did the Exosurf-treated lungs. After 30 min of ventilation with oxygen and fixation at 10 cm H2O pressure, the ratio of air space to tissue space was determined by a point-counting technique, and mean linear intercepts were measured for air spaces. Exosurf-treated lungs were intermediate between SAM and saline-treated lungs in both measurements. With positive pressure ventilation to maintain a tidal volume of 6.5 to 7.5 ml X kg-1, total compliance was significantly greater and inspiratory pressure significantly lower in both SAM- and Exosurf-treated animals than in saline-treated control animals, although the lungs of the SAM-treated animals were more compliant than the lungs of animals treated with Exosurf. During the first minute of positive pressure ventilation, lungs treated with SAM or Exosurf expanded equally rapidly, both expanding more rapidly than the saline-treated lungs.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们用一种名为Exosurf的合成表面活性剂治疗早产兔崽。按重量计,Exosurf含61.8%的二棕榈酰磷脂酰胆碱、6.8%的十六醇、4.6%的聚乙氧基月桂醇和26.7%的氯化钠。这种简单混合物以15mg脂质/1ml水的浓度悬浮,具有作为肺表面活性剂替代物的合适体外特性。通过通气30分钟后进行的静态压力-容积关系测定,用Exosurf治疗的肺在最大充气时接受的气体明显更多(36ml/kg体重对15ml/kg体重),并且在呼气时的容积明显大于用盐水治疗的对照肺;用天然兔表面活性剂(SAM)治疗的肺在最大充气时(65ml/kg体重对35ml/kg体重)和呼气时的容积明显大于用Exosurf治疗的肺。在用氧气通气30分钟并在10cmH₂O压力下固定后,通过点计数技术测定气腔与组织腔的比例,并测量气腔的平均线性截距。在这两项测量中,用Exosurf治疗的肺介于SAM治疗的肺和盐水治疗的肺之间。在正压通气以维持6.5至7.5ml/kg体重的潮气量时,SAM治疗组和Exosurf治疗组动物的总顺应性均显著高于盐水治疗的对照动物,吸气压力显著低于对照动物,尽管SAM治疗组动物的肺比Exosurf治疗组动物的肺更顺应。在正压通气的第一分钟内,用SAM或Exosurf治疗的肺扩张速度相同,两者都比用盐水治疗的肺扩张得更快。(摘要截短至250字)

相似文献

1
Lung function in prematurely delivered rabbits treated with a synthetic surfactant.用合成表面活性剂治疗的早产兔的肺功能
Am Rev Respir Dis. 1987 Sep;136(3):651-6. doi: 10.1164/ajrccm/136.3.651.
2
Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.羊膜腔内注射Exosurf对早产兔胎儿的影响。
Obstet Gynecol. 1992 Oct;80(4):604-8.
3
Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.棕榈酸考福昔酯(固尔苏)——用于未成熟肺的人工表面活性剂。
Drug Ther Bull. 1991 Jun 10;29(12):46.
4
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.一项针对体重1250克及以上患有呼吸窘迫综合征婴儿的合成表面活性剂对照试验。美国外源性表面活性物质新生儿研究组I和加拿大外源性表面活性物质新生儿研究组。
N Engl J Med. 1991 Dec 12;325(24):1696-703. doi: 10.1056/NEJM199112123252404.
5
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.一项多中心随机试验,比较合成表面活性剂与改良牛肺表面活性剂提取物治疗新生儿呼吸窘迫综合征。佛蒙特牛津新生儿网络。
Pediatrics. 1996 Jan;97(1):1-6.
6
Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.表面活性剂治疗后呼吸窘迫综合征婴儿的肺力学和能量学的产后变化。
Biol Neonate. 2005;87(4):323-31. doi: 10.1159/000084880. Epub 2005 Jun 1.
7
Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.新生儿的静态呼吸顺应性。III:外源性表面活性剂治疗后的早期变化。
Arch Dis Child Fetal Neonatal Ed. 1994 Jan;70(1):F19-24. doi: 10.1136/fn.70.1.f19.
8
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.棕榈酸考福斯昔尔。合成表面活性剂制剂(固尔苏)治疗新生儿呼吸窘迫综合征的疗效及临床耐受性综述。
Drugs. 1991 Nov;42(5):877-94. doi: 10.2165/00003495-199142050-00009.
9
Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep.
Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):1014-9. doi: 10.1164/ajrccm/141.4_Pt_1.1014.
10
[Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
Anesteziol Reanimatol. 1995 Jan-Feb(1):4-7.

引用本文的文献

1
Life-saving effect of pulmonary surfactant in premature babies.肺表面活性剂对早产儿的救生作用。
J Clin Invest. 2024 May 1;134(9):e179948. doi: 10.1172/JCI179948.
2
Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.喉罩气道表面活性物质给药预防有或有呼吸窘迫综合征风险的早产儿发病率和死亡率。
Cochrane Database Syst Rev. 2024 Jan 25;1(1):CD008309. doi: 10.1002/14651858.CD008309.pub3.
3
Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.
肺表面活性物质雾化给药联合经鼻持续气道正压通气治疗新生儿呼吸窘迫综合征
Front Pediatr. 2022 Jun 15;10:923010. doi: 10.3389/fped.2022.923010. eCollection 2022.
4
Targeted delivery of liquid microvolumes into the lung.将微量液体靶向递送至肺部。
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11530-5. doi: 10.1073/pnas.1512613112. Epub 2015 Aug 31.
5
Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.动物源性表面活性剂提取物与无蛋白合成表面活性剂用于预防和治疗呼吸窘迫综合征的比较
Cochrane Database Syst Rev. 2015 Aug 24;8(8):CD000144. doi: 10.1002/14651858.CD000144.pub3.
6
Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.用于患有或有呼吸窘迫综合征风险的早产儿的雾化表面活性剂
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008310. doi: 10.1002/14651858.CD008310.pub2.
7
Synthetic liposomes are protective from bleomycin-induced lung toxicity.合成脂质体可预防博来霉素引起的肺毒性。
Am J Physiol Lung Cell Mol Physiol. 2011 Aug;301(2):L207-17. doi: 10.1152/ajplung.00149.2010. Epub 2011 May 20.
8
Effect of nebulized bovine surfactant for experimental otitis media with effusion.雾化牛表面活性剂对实验性中耳炎伴积液的影响。
Clin Exp Otorhinolaryngol. 2010 Mar;3(1):13-7. doi: 10.3342/ceo.2010.3.1.13. Epub 2010 Mar 30.
9
Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.用于预防早产儿发病和死亡的预防性无蛋白合成表面活性剂。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD001079. doi: 10.1002/14651858.CD001079.pub2.
10
Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?用于新生儿呼吸窘迫综合征的肺表面活性剂:动物源制剂还是合成制剂?
Paediatr Drugs. 2002;4(8):485-92. doi: 10.2165/00128072-200204080-00001.